Send a Tweet
Most Popular Choices
Poll Analyses
Share on Facebook 4 Share on Twitter Printer Friendly Page More Sharing
General News   

MD Anderson Oncologist Stephen Hahn Confirmed as FDA Commissioner, Senate Vote 72-18

Author 4578
Message Stephen Fox
Become a Fan
  (31 fans)

Dr. Stephen Hahn FDA hearing Dr. Stephen Hahn responds to a question on dairy labeling from Sen. Tammy Baldwin at his confirmation hearing, Nov. 20, 2019.
Dr. Stephen Hahn FDA hearing Dr. Stephen Hahn responds to a question on dairy labeling from Sen. Tammy Baldwin at his confirmation hearing, Nov. 20, 2019.
(Image by YouTube, Channel: National Milk Producers Federation)
  Details   DMCA

Trump nominated Hahn last month to succeed former Commissioner Scott Gottlieb. National Cancer Institute Director Dr. Ned Sharpless and Department of Health and Human Services official Dr. Brett Giroir had been heading the FDA as acting commissioners. 

New therapies for serious diseases will come under FDA review on Hahn’s watch. Following the presentation of positive data at recent American Society of Hematology meetings, Bristol-Myers Squibb seeks approval for two CAR-T cell therapies – lisocabtagene maraleucel in diffuse large B-cell lymphoma and idecabtagene vicleucel in multiple myeloma. Gilead Sciences said Wednesday that it had filed for approval of KTE-X19 in mantle cell lymphoma as well. Bluebird plans to initiate a rolling application for the gene therapy LentiGlobin in the blood disorder beta-thalassemia, which won European Medicines Agency approval earlier this year.

Read the rest of the story HERE:

At medcitynews.com

 

Rate It | View Ratings

Stephen Fox Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Early in the 2016 Primary campaign, I started a Facebook group: Bernie Sanders: Advice and Strategies to Help Him Win! As the primary season advanced, we shifted the focus to advancing Bernie's legislation in the Senate, particularly the most (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: